Stephen Mullennix
2018
Compensation breakdown
Bonus | $70,000 |
---|---|
Non-Equity Incentive Plan | $223,400 |
Option Awards | $2,552,946 |
Salary | $359,754 |
Stock Awards | $1,102,893 |
Other | $575 |
Total | $4,309,568 |
Mullennix received $2.6M in option awards, accounting for 59% of the total pay in 2018.
Mullennix also received $70K in bonus, $223.4K in non-equity incentive plan, $359.8K in salary, $1.1M in stock awards and $575 in other compensation.
Rankings
In 2018, Stephen Mullennix's compensation ranked 2,521st out of 14,244 executives tracked by ExecPay. In other words, Mullennix earned more than 82.3% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 2,521 | 82nd |
Manufacturing | 929 | 84th |
Chemicals And Allied Products | 318 | 85th |
Drugs | 258 | 86th |
Pharmaceutical Preparations | 201 | 86th |
Mullennix's colleagues
We found six more compensation records of executives who worked with Stephen Mullennix at UroGen Pharma Ltd. in 2018.
2018
Ron Bentsur
UroGen Pharma Ltd.
Chief Executive Officer
2018
Gil Hakim
UroGen Pharma Ltd.
Former President
2018
Gary Titus
UroGen Pharma Ltd.
Chief Financial Officer
2018
Peter Pfreundschuh
UroGen Pharma Ltd.
Chief Financial Officer
2018
Peter Pfreundschuh
UroGen Pharma Ltd.
Chief Financial Officer
2018
Mark Schoenberg
UroGen Pharma Ltd.